Ernest T. Hawk, MD, MPH | Authors

Adenocarcinoma of the Esophagus: Risk Factors and Prevention

April 01, 2000

Esophageal cancer, with an estimated number of 12,300 new cases in the year 2000, is relatively uncommon in the United States but produces a high number of annual deaths, estimated at 12,100. Moreover, the incidence of the

Strategies for Identification and Clinical Evaluation of Promising Chemopreventive Agents

October 01, 1996

Strategies for chemopreventative drug development are based on the use of well-characterized agents, intermediate biomarkers correlating to cancer incidence, and suitable cohorts for efficacy studies. Since